NeuPath Health Inc
XTSX:NPTH
NeuPath Health Inc
XTSX:NPTH
Price:
0.59
CAD
-1.67%
Market Cap:
CA$33.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
NeuPath Health Inc
XTSX:NPTH
|
CA |
|
Haverty Furniture Companies Inc
NYSE:HVT
|
US |
|
Burberry Group PLC
F:BB2A
|
UK |
|
B
|
Boston Properties Inc
SWB:BO9
|
US |
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
IL |
|
T
|
TAAT Global Alternatives Inc
CNSX:TAAT
|
CA |
Wall St Price Targets
NPTH Price Targets Summary
NeuPath Health Inc
NeuPath Health Inc
Wall Street analysts forecast NPTH stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for NPTH is 0.78 CAD with a low forecast of 0.59 CAD and a high forecast of 1 CAD.
Lowest Forecast
Price Target
0.59
CAD
1% Downside
Average Forecast
Price Target
0.78
CAD
32% Upside
Highest Forecast
Price Target
1
CAD
69% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NPTH's stock price target?
Price Target
0.78
CAD
0.78
CAD
According to Wall Street analysts, the average 1-year price target for NPTH is 0.78 CAD with a low forecast of 0.59 CAD and a high forecast of 1 CAD.
What is the Revenue forecast for NeuPath Health Inc?
Projected CAGR
9%
9%
Over the last 7 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 2 years is 9%.
